The government did not keep any alternative source for importing Covid-19 vaccine to serve business interest of a particular company that have gained a huge profit, alleged Jatiya Party Chairman and Deputy Leader of the Opposition GM Quader yesterday.
It seemed that crores of taka are being misappropriated in the name of importing the vaccine through the company, he said.
In a statement, the JP chairman said now uncertainty has been created over vaccine management. "As a third party, a company has made profit of crores of taka but the guarantee of getting vaccine has not been ensured," he said.
GM Quader said according to media reports, a particular company that imported Covid-19 vaccine gained profit of Tk 77 for each ampule of vaccine. A stock market's website report says, it has earned Tk 38.367 crore by importing 50 lakh doses of vaccine from January to March.
The same company imported another two million doses of vaccine in April under the existing agreement, meaning that it has achieved a profit Tk 15.40 crore.
Quader said the supply of Covid-19 vaccine from India has suddenly been stopped and due to a lack of alternative source, the vaccination programme fell into extreme uncertainty.
"At a time when the epidemic is raging in Bangladesh, we are being forced to suspend the vaccination programme for want of vaccines," Quader added.
The JP chairman said doing business over import of Covid vaccine is not acceptable during the pandemic period.